148 related articles for article (PubMed ID: 15212311)
1. Possibilities in improvement of glucocorticoid treatments in asthma with special reference to loteprednol etabonate.
Szelenyi I; Hermann R; Petzold U; Pahl A; Hochhaus G
Pharmazie; 2004 May; 59(5):409-11. PubMed ID: 15212311
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis.
Ilyas H; Slonim CB; Braswell GR; Favetta JR; Schulman M
Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462
[TBL] [Abstract][Full Text] [Related]
3. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
Currie GP; Srivastava P; Dempsey OJ; Lee DK
QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
[TBL] [Abstract][Full Text] [Related]
7. Soft steroids: a new approach to the treatment of inflammatory airways diseases.
Belvisi MG; Hele DJ
Pulm Pharmacol Ther; 2003; 16(6):321-5. PubMed ID: 14580922
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy in asthma bronchiale in the new millennium.
Szelenyi I; Pahl A
Pharmazie; 2002 Feb; 57(2):83-6. PubMed ID: 11878194
[TBL] [Abstract][Full Text] [Related]
9. Change in intraocular pressure during long-term use of loteprednol etabonate.
Novack GD; Howes J; Crockett RS; Sherwood MB
J Glaucoma; 1998 Aug; 7(4):266-9. PubMed ID: 9713785
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies for allergic airways diseases.
Carlsen KH
Paediatr Respir Rev; 2004 Mar; 5(1):45-51. PubMed ID: 15222954
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
Gulliver T; Eid N
Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Can corticosteroids be beaten in future asthma therapy?
Amon A; Pahl A; Szelenyi I
Pharmazie; 2006 Feb; 61(2):122-4. PubMed ID: 16526559
[TBL] [Abstract][Full Text] [Related]
15. Management of seasonal allergic conjunctivitis: guide to therapy.
Bielory BP; O'Brien TP; Bielory L
Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
[TBL] [Abstract][Full Text] [Related]
16. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
Dodig S; Richter D; Cepelak I; Benko B
Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
[TBL] [Abstract][Full Text] [Related]
17. The hypothalamic-pituitary-adrenal axis in asthmatic children.
Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP
Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
Owen CE
Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
[TBL] [Abstract][Full Text] [Related]
20. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
Rice-McDonald G; Bowler S; Staines G; Mitchell C
Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
